About lab
IMMUNOTHERAPY WITH INTERLEUKIN-2: A STUDY BASED ONMATHEMATICAL MODELINGS ANDIP B ANERJEEIndian Institute of Technology and Science Rooorkee (IITR)Roorkee 247667, Uttarakhand, Indiae-mail: sandofma@iit. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.
Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagebanerjee2008-immunotherapy-with-interleukin-2-a-study-based-on-m
Created2026-05-15
Updated2026-05-15
immunologysbmlbiomodels_ebifaithfulcuratedvisualisation
Manifest
{
"io": {
"inputs": [
{
"name": "initial_unresolved_signaling_observable_1",
"label": "Initial Unresolved Signaling Observable 1",
"units": "native source value",
"default": 0,
"maps_to": "immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model.initial_unresolved_signaling_observable_1",
"description": "Initial Unresolved Signaling Observable 1. Sets the initial value of bundled SBML species `x`."
},
{
"name": "initial_unresolved_signaling_observable_2",
"label": "Initial Unresolved Signaling Observable 2",
"units": "native source value",
"default": 0.05,
"maps_to": "immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model.initial_unresolved_signaling_observable_2",
"description": "Initial Unresolved Signaling Observable 2. Sets the initial value of bundled SBML species `y`."
},
{
"name": "initial_unresolved_signaling_observable_3",
"label": "Initial Unresolved Signaling Observable 3",
"units": "native source value",
"default": 0.005,
"maps_to": "immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model.initial_unresolved_signaling_observable_3",
"description": "Initial Unresolved Signaling Observable 3. Sets the initial value of bundled SBML species `z`."
}
],
"outputs": [
{
"name": "unresolved_signaling_observable_1",
"maps_to": "immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model.unresolved_signaling_observable_1"
},
{
"name": "unresolved_signaling_observable_2",
"maps_to": "immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model.unresolved_signaling_observable_2"
},
{
"name": "unresolved_signaling_observable_3",
"maps_to": "immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model.unresolved_signaling_observable_3"
},
{
"name": "state",
"maps_to": "immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model.state"
},
{
"name": "summary",
"maps_to": "immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model.summary"
},
{
"name": "species_labels",
"maps_to": "immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model.species_labels"
}
]
},
"title": "Banerjee2008 - Immunotherapy with interleukin-2: A study based on mathematical modeling Lab",
"models": [
{
"path": "owned/models/immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model",
"alias": "immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model",
"provenance": {
"owned_path": "owned/models/immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model_state"
],
"from": "immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model.state"
},
{
"to": [
"visualisation.immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model_summary"
],
"from": "immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model.summary"
},
{
"to": [
"visualisation.immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model_species_labels"
],
"from": "immunology_sbml_banerjee2008_immunotherapy_with_interleukin_2_a_model2001130001_model.species_labels"
}
],
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"description": "IMMUNOTHERAPY WITH INTERLEUKIN-2: A STUDY BASED ONMATHEMATICAL MODELINGS ANDIP B ANERJEEIndian Institute of Technology and Science Rooorkee (IITR)Roorkee 247667, Uttarakhand, Indiae-mail: sandofma@iit. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.